Bio-Rad Laboratories | BIO - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Abbott USD 9.31B 104M 2026-03
Agilent USD 1.44B 27M 2025-12
Becton, Dickinson and Co. USD 24.13B 19.54B 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
Bio-Rad Laboratories USD 6.85B 6.21B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Danaher USD 52.95B 47.61B 2026-03
General Electric Aerospace USD 18.06B 7.11B 2026-03
Illumina USD 852M 51M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Laboratory Of America USD 3.13B 6.3M 2026-03
Merck USD 18.17B 8.01B 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Quest Diagnostics USD 2.5B 76M 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Siemens EUR 16.57B 2.29B 2025-12
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Tosoh JPY 238.2B 6.41B 2026-03
Waters USD 1.12B 457.15M 2026-03